Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Kintara Therapeutics Inc. Stock

Price
Target price
-

-

-
-
-
-
 
WKN: A2QBU5 / Name: Kintara Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Kintara Therapeutics Inc. in the next few years
Wizard

Kintara Therapeutics Inc. Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kintara Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
What does Kintara Therapeutics do?

Pros and Cons of Kintara Therapeutics Inc. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-02

The financials of Kintara Therapeutics provide an interesting insight into their current standing in the industry. At first glance, it seems that the company has been struggling financially, with negative net incomes and operating losses in recent years. However, diving deeper into the financial statements may reveal more nuances in their financial health.

Growth in Total Assets: Over the years, Kintara Therapeutics has demonstrated growth in their total assets. From 2020 to 2022, the total assets increased from approximately $2.94 million to $15.95 million, indicating an improvement in the company's financial position.

Reduction in Net Debt: The company's net debt has been decreasing, with a substantial decrease between 2021 and 2022, where it went from $-10.54 million to $-11.78 million. This improvement in net debt suggests that Kintara Therapeutics has been managing its liabilities efficiently.

Show more
Register To Post